Prognos raises $20.5 mln from Cigna, Hermed, Hikma, Maywic, Merck, Safeguard, GIS Strategic

Prognos said it raised $20.5 million of Series C capital in a round backed by Cigna, Hermed, Hikma Ventures, Maywic, Merck Global Health Innovation Fund, Safeguard Scientifics and GIS Strategic Ventures, the venture capital arm of Guardian Life Insurance.

The financing brings capital raised by the company to $42 million.

Prognos is using artificial intelligence to gain real-time insights from laboratory and diagnostics records.